Works by Chung-Cheng Huang


Results: 54
    1
    2
    3
    4
    5

    Comparison of afatinib and erlotinib combined with bevacizumab in untreated stage IIIB/IV epidermal growth factor receptor-mutated lung adenocarcinoma patients: a multicenter clinical analysis study.

    Published in:
    Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221113278
    By:
    • Lee, Suey-Haur;
    • Lin, Yu-Ching;
    • Chiu, Li-Chung;
    • Ju, Jia-Shiuan;
    • Tung, Pi-Hung;
    • Huang, Allen Chung-Cheng;
    • Li, Shih-Hong;
    • Fang, Yueh-Fu;
    • Chen, Chih-Hung;
    • Kuo, Scott Chih-Hsi;
    • Wang, Chin-Chou;
    • Yang, Cheng-Ta;
    • Hsu, Ping-Chih
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32

    Front‐line treatment of ceritinib improves efficacy over crizotinib for Asian patients with anaplastic lymphoma kinase fusion NSCLC: The role of systemic progression control.

    Published in:
    Thoracic Cancer, 2019, v. 10, n. 12, p. 2274, doi. 10.1111/1759-7714.13221
    By:
    • Huang, Shih‐Hao;
    • Huang, Allen Chung‐Cheng;
    • Wang, Chin‐Chou;
    • Chang, Wen‐Chen;
    • Liu, Chien‐Ying;
    • Pavlidis, Stelios;
    • Ko, Ho‐Wen;
    • Chung, Fu‐Tsai;
    • Hsu, Ping‐Chih;
    • Guo, Yi‐Ke;
    • Kuo, Chih‐Hsi Scott;
    • Yang, Cheng‐Ta
    Publication type:
    Article
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50